Success Metrics

Clinical Success Rate

93.1%

Based on 27 completed trials

Completion Rate

93%(27/29)

Active Trials

4(11%)

Results Posted

67%(18 trials)

Terminated

2(5%)

Phase Distribution

Ph phase_3

Ph not_applicable

42%

Ph phase_2

37%

Ph phase_1

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution37 total trials

Phase 1Safety & dosage

3(8.1%)

Phase 2Efficacy & side effects

14(37.8%)

Phase 3Large-scale testing

2(5.4%)

Phase 4Post-market surveillance

2(5.4%)

N/ANon-phased studies

16(43.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

27 of 33 finished

Non-Completion Rate

18.2%

6 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(27)

Terminated(6)

Other(1)

Detailed Status

Completed27

Withdrawn4

Recruiting3

Terminated2

unknown1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

93.1%

Most Advanced

Phase 4

Trials by Phase

Phase 13 (8.1%)

Phase 214 (37.8%)

Phase 32 (5.4%)

Phase 42 (5.4%)

N/A16 (43.2%)

Trials by Status

completed2771%

unknown13%

withdrawn411%

active_not_recruiting13%

terminated25%

recruiting38%

Recent Activity

4 active trials

Showing 5 of 38

recruitingnot_applicable

Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder

NCT07054697

View all 38 trials

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more

NCT07147205Not Applicable

Evaluation of Meaning-centered Group Psychotherapy in Integrative Medicine

Recruiting

NCT05866185Not Applicable

Improving Adherence to Homework During Therapy

Completed

NCT07161804Phase 4

Pilot RCT Using Homeopathic Medicines in ASD

Completed

NCT06514495Not Applicable

Differential Effects of in Vivo and Virtual Exposure Therapy in Agoraphobia

Recruiting

NCT07054697Phase 4

Pilot-RCT With Individualized Homeopathic Treatment in the Children With Autism Spectrum Disorder

Completed

NCT03537014Phase 3

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Completed

NCT00090064Phase 2

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

Completed

NCT04077437Phase 3

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2)

Completed

NCT02427568Phase 2

MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness

Completed

NCT02008396Phase 2

Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults

Completed

NCT01211405Phase 2

Study Comparing Three Doses of MDMA Along With Therapy in Veterans With Posttraumatic Stress Disorder

Completed

NCT02876172Phase 1

MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD

Completed

NCT05790239Phase 2

MDMA-Assisted Therapy for Veterans With Moderate to Severe Post Traumatic Stress Disorder

Recruiting

NCT02102802

Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD

Completed

NCT04968938Phase 2

Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

Withdrawn

NCT04073433Phase 1

Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2)

Withdrawn

NCT04454684Phase 2

A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders

Withdrawn

NCT05173831Phase 2

Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans

Withdrawn

NCT00182728Not Applicable

Radiation Therapy During Surgery in Treating Older Women With Invasive Breast Cancer

Completed

NCT00353938Phase 2

Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder

Completed

Drug Details

Intervention Type: OTHER
Total Trials: 38